当前位置: 首页 >> 检索结果
7141. Efficacy and safety of Sandoz biosimilar rituximab for active rheumatoid arthritis: 52-week results from the randomized controlled ASSIST-RA trial.
作者: Josef S Smolen.;Stanley B Cohen.;Hans-Peter Tony.;Morton Scheinberg.;Alan Kivitz.;Andra Balanescu.;Juan Gomez-Reino.;Liyi Cen.;Johann Poetzl.;Tamas Shisha.;Dmitrij Kollins.
来源: Rheumatology (Oxford). 2021年60卷1期256-262页
This report provides data for the extent of B cell depletion and recovery, efficacy, safety and immunogenicity of Sandoz rituximab (SDZ-RTX; GP2013; Rixathon®) compared with reference rituximab (Ref-RTX) up to week 52 of the ASSIST-RA study.
7142. Chest wall muscle atrophy as a contributory factor for forced vital capacity decline in systemic sclerosis-associated interstitial lung disease.
作者: Takashi Nawata.;Yuichiro Shirai.;Mikito Suzuki.;Masataka Kuwana.
来源: Rheumatology (Oxford). 2021年60卷1期250-255页
To investigate the potential contribution of accessory respiratory muscle atrophy to the decline of forced vital capacity (FVC) in patients with SSc-associated interstitial lung disease (ILD).
7143. Ultrasound for the diagnosis of gout-the value of gout lesions as defined by the Outcome Measures in Rheumatology ultrasound group.
作者: Sara Nysom Christiansen.;Mikkel Østergaard.;Ole Slot.;Viktoria Fana.;Lene Terslev.
来源: Rheumatology (Oxford). 2021年60卷1期239-249页
To evaluate ultrasound for diagnosing gout using consensus-based Outcome Measures in Rheumatology ultrasound definitions of gout lesions.
7144. Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children.
作者: Mao Mizuta.;Masaki Shimizu.;Hitoshi Irabu.;Masaaki Usami.;Natsumi Inoue.;Yasuo Nakagishi.;Taizo Wada.;Akihiro Yachie.
来源: Rheumatology (Oxford). 2021年60卷1期231-238页
To compare the cytokines involved in the development of macrophage activation syndrome (MAS) in different background rheumatic diseases and to identify serum biomarkers for MAS diagnosis.
7145. Immune responses after influenza vaccination in patients of primary Sjögren's syndrome.
作者: Xingyu Zhou.;Yisi Liu.;Yuebo Jin.;Yifan Wang.;Miao Miao.;Jiali Chen.;Yaobin Cheng.;Yudong Liu.;Jing He.;Zhanguo Li.
来源: Rheumatology (Oxford). 2021年60卷1期224-230页
Influenza vaccination is effective in preventing infections in most people. This study aimed to assess the changes of immune responses in primary Sjögren's Syndrome (pSS) patients after influenza vaccination and determine the safety of influenza vaccination.
7146. Performance of the 2019 ACR/EULAR classification criteria for IgG4-related disease and clinical phenotypes in a Spanish multicentre registry (REERIGG4).
作者: Andreu Fernández-Codina.;Blanca Pinilla.;Iago Pinal-Fernández.;Iago Carballo.;Carlos Feijoo-Massó.;María Toledano-Macías.;Borja de Miguel-Campo.;Eva Fonseca-Aizpuru.;Luis Sáez-Comet.;Miguel López-Dupla.;José Hernández-Rodríguez.;Fernando Martínez-Valle.
来源: Rheumatology (Oxford). 2021年60卷1期217-223页
Several IgG4-related disease (IgG4-RD) phenotypes have been proposed and the first set of classification criteria have been recently created. Our objectives were to assess the phenotype distribution and the performance of the classification criteria in Spanish patients as genetic and geographical differences may exist.
7147. Biomarkers for treatment change and radiographic progression in patients with rheumatoid arthritis in remission: a 5 year follow-up study.
作者: Julio Ramírez.;Andrea Cuervo.;Raquel Celis.;Virginia Ruiz-Esquide.;Raul Castellanos-Moreira.;José Antonio Narváez.;José A Gómez-Puerta.;José L Pablos.;Raimon Sanmartí.;Juan D Cañete.
来源: Rheumatology (Oxford). 2021年60卷2期667-674页
To identify biomarkers of treatment change and radiographic progression in patients with RA under remission.
7149. Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls.
作者: Irene E M Bultink.;Frank de Vries.;Ronald F van Vollenhoven.;Arief Lalmohamed.
来源: Rheumatology (Oxford). 2021年60卷1期207-216页
We wanted to estimate the magnitude of the risk from all-cause, cause-specific and sex-specific mortality in patients with SLE and relative risks compared with matched controls and to evaluate the influence of exposure to medication on risk of mortality in SLE.
7152. The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study.
作者: Lingyi Li.;Na Lu.;Ana Michelle Avina-Galindo.;Yufei Zheng.;Diane Lacaille.;John M Esdaile.;Hyon K Choi.;J Antonio Aviña-Zubieta.
来源: Rheumatology (Oxford). 2021年60卷1期188-195页
To estimate the overall risk of venous thromboembolism (VTE), pulmonary embolism (PE) and deep vein thrombosis (DVT) among patients newly diagnosed with RA compared with the general population without RA; and to estimate the risk trends of VTE, PE and DVT after RA diagnosis up to 5 years compared with the general population.
7153. Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS).
作者: Renata F Rosa.;Michelle Remião Ugolini-Lopes.;Ana Paula Rossi Gandara.;Margarete B G Vendramini.;Kenia Repiso Campanholo.;Livia Dutra.;Danieli Castro Oliveira de Andrade.
来源: Rheumatology (Oxford). 2021年60卷1期179-187页
Cognitive dysfunction (CD) is a poorly understood non-stroke central neurological manifestation in anti-phospholipid syndrome (APS). Brain-derived neurotrophic factor (BDNF) is a neurotrophin that plays an important role in neural plasticity and could potentially be a biomarker of CD in primary APS (PAPS). The aim of the study is to assess CD in PAPS patients and to evaluate its association with clinical data, anti-phospholipid antibodies and serum BDNF levels.
7154. The iCanCope pain self-management application for adolescents with juvenile idiopathic arthritis: a pilot randomized controlled trial.
作者: Chitra Lalloo.;Lauren R Harris.;Amos S Hundert.;Roberta Berard.;Joseph Cafazzo.;Mark Connelly.;Brian M Feldman.;Kristin Houghton.;Adam Huber.;Ronald M Laxer.;Nadia Luca.;Heinrike Schmeling.;Lynn Spiegel.;Lori B Tucker.;Quynh Pham.;Cleo C Davies-Chalmers.;Jennifer N Stinson.
来源: Rheumatology (Oxford). 2021年60卷1期196-206页
To evaluate the feasibility and preliminary effectiveness of iCanCope with Pain (iCanCope), a smartphone-based pain self-management program, in adolescents with JIA. iCanCope featured symptom tracking, goal-setting, pain coping skills and social support.
7155. Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study.
作者: Stylianos Panopoulos.;Konstantinos Thomas.;Georgios Georgiopoulos.;Dimitrios Boumpas.;Christina Katsiari.;George Bertsias.;Alexandros A Drosos.;Kyriaki Boki.;Theodoros Dimitroulas.;Alexandros Garyfallos.;Charalampos Papagoras.;Pelagia Katsimbri.;Apostolos Tziortziotis.;Christina Adamichou.;Evripidis Kaltsonoudis.;Evangelia Argyriou.;Georgios Vosvotekas.;Petros P Sfikakis.;Dimitrios Vassilopoulos.;Maria G Tektonidou.
来源: Rheumatology (Oxford). 2021年60卷1期170-178页
Evidence on comorbidity prevalence in antiphospholipid syndrome (APS) and its difference from high comorbidity burden rheumatic diseases is limited. Herein, we compare multiple comorbidities between APS and RA.
7156. Glucocorticoid use is associated with an increased risk of hypertension.
作者: Ruth E Costello.;Belay B Yimer.;Polly Roads.;Meghna Jani.;William G Dixon.
来源: Rheumatology (Oxford). 2021年60卷1期132-139页
Patients with RA are frequently treated with glucocorticoids (GCs), but evidence is conflicting about whether GCs are associated with hypertension. The aim of this study was to determine whether GCs are associated with incident hypertension in patients with RA.
7157. Translating research into clinical practice: quality improvement to halve non-adherence to methotrexate.
作者: Anne Barton.;Meghna Jani.;Christine Bundy.;James Bluett.;Stephen McDonald.;Brian Keevil.;Faraz Dastagir.;Melissa Aris.;Ian Bruce.;Pauline Ho.;Eoghan McCarthy.;Ellen Bruce.;Ben Parker.;Kimme Hyrich.;Rachel Gorodkin.
来源: Rheumatology (Oxford). 2021年60卷1期125-131页
MTX remains the cornerstone for therapy for RA, yet research shows that non-adherence is significant and correlates with response to therapy. This study aimed to halve self-reported non-adherence to MTX at the Kellgren Centre for Rheumatology.
7158. Initial analgesic prescriptions for osteoarthritis in the United Kingdom, 2000-2016.
作者: Chao Zeng.;Weiya Zhang.;Michael Doherty.;Monica S M Persson.;Christian Mallen.;Subhashisa Swain.;Xiaoxiao Li.;Jie Wei.;Guanghua Lei.;Yuqing Zhang.
来源: Rheumatology (Oxford). 2021年60卷1期147-159页
To examine trends in the initial prescription of commonly-prescribed analgesics and patient- as well as practice-level factors related to their selection in incident OA.
7159. Arthritis autoantibodies in individuals without rheumatoid arthritis: follow-up data from a Dutch population-based cohort (Lifelines).
作者: Johanna Westra.;Elisabeth Brouwer.;Elisabeth Raveling-Eelsing.;Suzanne Arends.;Amaal Eman Abdulle.;Caroline Roozendaal.;Myrthe A M van Delft.;Rene E M Toes.;Leendert A Trouw.;Arjan Vissink.;Menke J de Smit.
来源: Rheumatology (Oxford). 2021年60卷2期658-666页
To assess whether the presence of arthritis autoantibodies alongside IgG ACPA predicts clinically suspect arthralgia in ACPA-positive subjects without RA.
7160. Beneficial effect of Mediterranean diet on disease activity and cardiovascular risk in systemic lupus erythematosus patients: a cross-sectional study.
作者: Gabriela Pocovi-Gerardino.;María Correa-Rodríguez.;José-Luis Callejas-Rubio.;Raquel Ríos-Fernández.;María Martín-Amada.;María-Gracia Cruz-Caparros.;Blanca Rueda-Medina.;Norberto Ortego-Centeno.
来源: Rheumatology (Oxford). 2021年60卷1期160-169页
To analyse the influence of the Mediterranean diet (Med Diet) on SLE activity, damage accrual and cardiovascular disease risk markers.
|